Ko Sung-Jun, Lee Yeon Joo, Park Jong Sun, Cho Young-Jae, Yoon Ho Il, Chung Jin-Haeng, Kim Tae Jung, Lee Kyung Won, Kim Kwhanmien, Jheon Sanghoon, Kim Hyojin, Lee Jae Ho, Lee Choon-Taek
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
BMC Cancer. 2014 May 3;14:312. doi: 10.1186/1471-2407-14-312.
Nodular ground-glass opacities (nGGO) are a specific type of lung adenocarcinoma. ALK rearrangements and driver mutations such as EGFR and K-ras are frequently found in all types of lung adenocarcinoma. EGFR mutations play a role in the early carcinogenesis of nGGOs, but the role of ALK rearrangement remains unknown.
We studied 217 nGGOs resected from 215 lung cancer patients. Pathology, tumor size, tumor disappearance rate, and the EGFR and ALK markers were analyzed.
All but one of the resected nGGOs were adenocarcinomas. ALK rearrangements and EGFR mutations were found in 6 (2.8%) and 119 (54.8%) cases. The frequency of ALK rearrangement in nGGO was significantly lower than previously reported in adenocarcinoma. Advanced disease stage (p = 0.018) and larger tumor size (p = 0.037) were more frequent in the ALK rearrangement-positive group than in ALK rearrangement-negative patients. nGGOs with ALK rearrangements were associated with significantly higher pathologic stage and larger maximal and solid diameter in comparison to EGFR-mutated lesions.
ALK rearrangement is rare in lung cancer with nGGOs, but is associated with advanced stage and larger tumor size, suggesting its association with aggressive progression of lung adenocarcinoma. ALK rearrangement may not be important in early pathogenesis of nGGO.
结节状磨玻璃影(nGGO)是肺腺癌的一种特殊类型。在所有类型的肺腺癌中,ALK重排以及诸如EGFR和K-ras等驱动基因突变都很常见。EGFR突变在nGGO的早期致癌过程中发挥作用,但ALK重排的作用尚不清楚。
我们研究了从215例肺癌患者中切除的217个nGGO。分析了病理、肿瘤大小、肿瘤消失率以及EGFR和ALK标志物。
除1例切除的nGGO外,其余均为腺癌。在6例(2.8%)和119例(54.8%)病例中发现了ALK重排和EGFR突变。nGGO中ALK重排的频率显著低于先前报道的腺癌。ALK重排阳性组的疾病晚期(p = 0.018)和肿瘤较大(p = 0.037)的情况比ALK重排阴性患者更常见。与EGFR突变的病变相比,伴有ALK重排的nGGO与显著更高的病理分期以及更大的最大直径和实性直径相关。
ALK重排在伴有nGGO的肺癌中罕见,但与晚期和更大的肿瘤大小相关,提示其与肺腺癌的侵袭性进展有关。ALK重排在nGGO的早期发病机制中可能并不重要。